Retired United States Navy Commander and Current Director of Asset Management at Exelon Generation David B. Lillefloren, has recently been appointed to the Maryland Chapter of the Cystic Fibrosis Foundation, Board of Directors. The Cystic Fibrosis Foundation is the world’s leader in the search for a cure for Cystic Fibrosis. Cystic Fibrosis or (CF) is a life-threatening, inherited chronic disease that obstructs the lungs and digestive system of about 30,000 children and adults in the United States (70,000 worldwide). Though the Maryland Chapter is one of the smallest chapters of CF Foundation, it consistently leads the nation within the CF Foundation, through active volunteer participation and substantial fund-raising successes. The Board of Directors is comprised of some of the Mid-Atlantic region’s most dynamic and influential people, who have a proven track record in leadership and fund-raising capabilities. Members of the Board of Directors not only provide leadership for implementation of the chapter’s strategic plan and an annual personal financial commitment to the foundation, but they also actively participate in fundraising events. They are tasked with providing invaluable resources, which are critical for CF Foundation to continue with its vital mission of curing and controlling CF through groundbreaking research and medical advancements.
David Lillefloren, a former United States Navy Commander, has earned a Bachelor of Science from the United States Naval Academy, and a Master in Public Administration from Troy University. David served seven years, active duty in the United States Navy and 13 years in the Navy Reserves, with assignments on the USS Fairfax County, USS Elrod, the United States Naval Academy, NOSC Lexington, KY, and NOSC Baltimore, MD. David is now Director of Asset Manager for Exelon Generation. David represents Exelon on partnerships consisting of 1500 MW (Mega Watts) of energy assets. He also was instrumental in the successful 7.8 billion dollar merger of Exelon and Constellation Energy. David is now dedicating his ingenuity to help those who suffer from CF. He is committed to support finding a cure for this disease and serves as the co-chair for the Foundation’s Evening on the Severn event. David has pledged to use every resource at his disposal to help the CF Foundation reach its goal, finding the cure. David comments, “I am honored to be a part of such a great organization. The more CF families I meet, the more I want to find a CURE! I am ALL IN until we do!” David resides in Annapolis with his devoted wife of 20 years, Patricia and their three daughters Mary, Anne, and Kathryn.
The Cystic Fibrosis Foundation’s focus is to support the development of new drugs to fight CF, improve the quality of life for those with CF, and ultimately to find a cure for all CF patients. Currently, the Foundations efforts have produced drug therapies that have increased the life expectancy for CF patients from 5 years of age to over 40 years of age. Much of the Foundation’s effectiveness in fighting CF can be attributed to its efficient use of charitable funding. Over 90% of every dollar raised supports CF research, patient/family care, and education programs. The Foundation's drug development success has been recognized by Harvard Business School and by publications such as Forbes, Discover magazine, and The Wall Street Journal. With the support of its Board of Directors, the Maryland Chapter of the CF Foundation alone generates an approximately net $3.5 million annually. For more information about the Maryland Chapter of Cystic Fibrosis Foundation, please visit: http://www.cff.org/chapters/maryland/.